The abstract is read at the publisher; the summary is JClub's.
Tissue-of-origin aging clocks across breast and five other cancers decompose tumor deviations into composite states where proliferative pathways look youth-like while damage-response and signaling look older-like.
- Why it matters: It remains unclear whether tumors keep or diverge from tissue-specific aging programs, limiting how aging clocks should be interpreted in cancer.
- What they did: The study built tissue-of-origin aging clocks and used ClockSHAP to attribute each tumor’s deviation from expected tissue aging to pathway-level contributions, then validated in breast cancer with a normal-trained clock.
- The result: In two independent breast cancer cohorts of ~9,700 tumors, the normal-trained clock reproduced deviations and pathway structure without retraining, aligned with molecular subtype and TP53 mutation status, and predicted survival.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.